WHC is still in active development. Read this to understand our approach.
depiction of XADCESSVHJOZHK-UHFFFAOYSA-N.svg
tripsit

demerol

Check on tripsit

psychonaut

Pethidine

Check on psychonaut

isomerdesign

Meperidine

Check on isomerdesign

pubchem

Meperidine

Check on pubchem

druglab

Péthidine

Check on druglab

drugmap

Meperidine

Check on drugmap

wiki

Pethidine

Check on wiki

Data

InChI: InChI=1S/C15H21NO2/c1-3-18-14(17)15(9-11-16(2)12-10-15)13-7-5-4-6-8-13/h4-8H,3,9-12H2,1-2H3

Synonyms: Pethidin, Isonipecotic acid, 1-methyl-4-phenyl-, ethyl ester,DEA No. 9230, Operidine EPJ I, Ethyl 1-methyl-4-phenylpiperidine-4-carboxylate,Q55434, 4-Piperidinecarboxylic acid, 1-methyl-4-phenyl-, ethyl ester,Pethidine (Meperidine) 0.1 mg/ml in Methanol,Pethidine [INN], Pethidine,UNII-9E338QE28F,4-Carbethoxy-1-methyl-4-phenylpiperidine, Petydyna, Isonipecaine,Petydyna,Pipersal, Methyl phenylpiperidine carbonic acid ethyl ester,Renaudin,Pethidinum, Pipersal, Pethidineter,YIsonipecotic acid, 1-methyl-4-phenyl-, ethyl ester (8CI), Petidina,Lidol (Salt/Mix),MEPERIDINE [VANDF],meperidine,Petidina, Pethidinum [INN-Latin], 1-Methyl-4-phenylisonipecotic acid, ethyl ester,SR-01000944492-1,Piridosal (Salt/Mix), Pethidine DBL,Mepridine, Piperosal,DB-053051,Isonipecotic acid, 1-methyl-4-phenyl-, ethyl ester,Ethyl 1-methyl-4-phenylpiperidine-4-carboxylate,1-Methyl-4-phenyl-4-piperidinecarboxylic acid ethyl ester,Dolsin (Salt/Mix),Dolantin (Salt/Mix),Pethidine DBL (TN),1-Methyl-4-phenylpiperidine-4-carboxylic acid ethyl ester,Dolosal (Salt/Mix),Nemerol,1-Methyl-4-phenyl-piperidine-4-carboxylic acid ethyl ester,NINDS_000983,57-42-1,Pethidineter,PETHIDINE [WHO-DD],Meperidine solution, 1 mg/mL in methanol, drug standard, Demerol,Petidina [INN-Spanish], Dolcontral, Dolosal, Meperidol,Petydyna [Polish],CHEBI:6754,4-Ethoxycarbonyl-1-methyl-4-phenyl-piperidinium, Pethidinum,ZINC1681, Pethanol,MEPERIDINE [MI],9E338QE28F, N-Methyl-4-phenyl-4-carbethoxypiperidine,1-Methyl-4-phenylisonipecotic acid, ethyl ester,Pethidine (INN), YIsonipecotic acid, 1-methyl-4-phenyl-, ethyl ester (8CI),Operidine (Salt/Mix),Pethidine DBL, Isonipecain,Dolcontral (Salt/Mix),MEPERIDINE [HSDB],Petantin (Salt/Mix),C07128,Meperidol,Ethyl 1-methyl-4-phenyl-4-piperidinecarboxylate,IDI1_000983,Pethidine, 1-Methyl-4-phenyl-piperidin-4-carbon-saeure-aethylester,Pethanol, 1-Methyl-4-phenyl-piperidin-4-carbon-saeure-aethylester [German],1-Methyl-4-phenyl-piperidin-4-carbon-saeure-aethylester,SCHEMBL25431,Centralgin (Salt/Mix), Operidine EPJ-I,4-Piperidinecarboxylic acid, 1-methyl-4-phenyl-, ethyl ester,Ethyl 1-methyl-4-phenylisonipecotate, Ethyl 1-methyl-4-phenylisonipecotate, Demerol (TN),EINECS 200-329-1,1-Methyl-4-phenyl-piperidine-4-carboxylic acid ethyl ester(Meperidine),DTXSID9023253,N-Methyl-4-phenyl-4-carbethoxypiperidine,Pethidinum [INN-Latin],1-methyl-4-phenylisonipecotic acid ethyl ester,Piperosal,Isonipecaine, Petydyna [Polish],Demerol,Meperidine, Meperidine solution,Pethidine [INN:BAN],CHEMBL607,pethidine,L000908, Nemerol,1-Methyl-4-phenyl-piperidin-4-carbon-saeure-aethylester [German], Pethidin, Pethidine (INN),DB00454,HSDB 3116, 1-Methyl-4-phenyl-4-piperidinecarboxylic acid ethyl ester,Phetidine,Ethyl(1-methyl-4-phenylpiperidin-4-carboxylate),DivK1c_000983,Meperidine solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Lydol, 4-Carbethoxy-1-methyl-4-phenylpiperidine,Demarol, Petidina [INN-Spanish],meperidina,SR-01000944492, Pethidine DBL (TN),Lydol (Salt/Mix),Pethidine (Meperidine) 1.0 mg/ml in Methanol,Dolaren (Salt/Mix),Dispadol (Salt/Mix),KBio1_000983, Lidol,D08343, Phetidine,IDS-NP-001,GTPL7221,Methyl phenylpiperidine carbonic acid ethyl ester,BDBM50026752, Dolsin


Estimated data

Solubility: -2.243 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 85.6% (prediction based on www.mdpi.com)

Similarities

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.